Cyxone investor relations material
Listen to the latest call from Cyxone
Cyxone AB (publ) is a clinical biotech company focusing on the development of new therapies to treat autoimmune diseases and acute respiratory disorders. The company's lead products include Cyxonexim (rheumatoid arthritis), and Cyxonidexim (multiple sclerosis).
Ticker
CYXOCountry
SEAbout
IR-page